Could a tiny ear device beat cancer fatigue?
NCT ID NCT07529431
First seen Apr 18, 2026 · Last updated Jun 22, 2026 · Updated 13 times
Summary
This study tests whether a small, non-invasive device that stimulates a nerve in the ear can help reduce fatigue in cancer patients receiving immunotherapy. Thirteen adults with advanced cancer and significant fatigue will use the device at home for 60 minutes daily over six weeks. The main goal is to see if patients can stick with the routine and if the device is safe, while also checking for any improvement in tiredness and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER-RELATED FATIGUE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
transcutaneous vagus nerve stimulation (tVNS) device
What this could lead to
If it works, this could point toward a new, drug-free way to manage severe fatigue in cancer patients on immunotherapy.
What could go wrong
This is a very small early feasibility study with only 13 participants. It is designed to test if the device can be used at home, not yet to prove it reduces fatigue.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.